News | May 19, 2026
Lupin debuts in Dow Jones best-in-class indices for ESG performance
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Subscribe To Our Newsletter & Stay Updated
